COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Bringing next-gen cannabinoid therapeutics to cancer patients
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
The new program includes upstream and downstream process development and large-scale GMP production.
_256_384.png)
Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
